Abbott Laboratories closed $8.24 below its 52-week high ($121.64), which the company achieved on March 8th.

North Chicago-based Abbott announced last month it reached a settlement agreement with Dexcom over all outstanding patent disputes relating to their glucose monitoring products, which estimate blood ...

Shares of Abbott Laboratories ABT shed 0.69% to $113.04 Monday, on what proved to be an all-around mixed trading session for ...

We recently compiled a list of the 10 Best January Dividend Stocks To Buy. In this article, we are going to take a look at ...

In a report released on January 6, Shagun Singh Chadha from RBC Capital maintained a Buy rating on Abbott Laboratories (ABT – Research Report), ...

Abbott Laboratories (ABT) stock saw a modest uptick, ending the day at $113.83 which represents a slight increase of $0.39 or 0.34% from the prior close of $113.44. The stock opened at $113.94 and ...

North Chicago, Illinois-based Abbott Laboratories (ABT) discovers, develops, manufactures, and sells healthcare products.

In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Abbott Laboratories (ABT – Research Report). The ...

Abbott Laboratories agreed to settle claims from a laid-off worker that the company engaged in pregnancy discrimination by ...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility ...